baber/WOPTO huggingface dataset:
Patent JP-3161259-B2 (JP)
IPC: F21Y101/00
Filed: 1994-12-14
Granted: 2001-04-25
Abstract: An optical axis adjusting device for a front illumination lamp has a drive rod (28) and a motor (29) for moving the drive rod (28) forwardly and backwardly. An optical axis of the lamp is adjusted by forward/backward movement of the drive rod (28). The optical axis adjusting device for a front illumination lamp further has a position detecting sensor (38). The position detecting sensor (38) has a movable element (35) capable of moving in unison with the forward/backward movement of the drive rod (28) and a stator (36) for detecting a forward/backward position of the drive rod (28) by co-acting with the movable element (35). <IMAGE>
Patent JP-2710652-B2 (JP)
IPC: C07D413/12
Filed: 1988-12-12
Granted: 1998-02-10
Abstract: 2-Tert.-butyl-5-isoxazolylmethylthio-3(2H)-pyridazin-3-one derivatives of the general formula 
<IMAGE>
 in which the substituents have the following meanings:
 R<1> represents hydrogen or C1-C4-alkyl,
 R<2> represents hydrogen, C1-C8-alkyl, C2-C8-alkenyl, C1-C4-haloalkyl, C2-C8-alkoxyalkyl, C3-C10-cycloalkyl, C2-C5-alkoxycarbonyl, aryl, C7-C20-aralkyl, aryl which is monosubstituted to trisubstituted by halogen, C1-C8-alkyl, C1-C8-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy, phenyl, phenoxy, cyano and/or mono- to disubstituted by nitro, or represents C7-C20-aralkyl which is substituted in the aryl moiety,
 R<3> represents hydrogen, halogen, C1-C8-alkyl or C2-C8-alkenyl and
 X represents chlorine or bromine,
 their preparation, and their use for controlling pests.
Patent JP-2849060-B2 (JP)
IPC: A61M39/20
Filed: 1995-12-06
Granted: 1999-01-20
Abstract: The protective cap (6) is permanently fixed to the counterpiece (2) by the first connection (8). At least one further connection (9) detachably joins the protective cap to the tube (1) or pipe. The first connection consists of a screw fastening acting in only one direction, or of a saw-toothed rotary element. At least one protuberance fits into a groove. A further connection consists of a screw, plug-in, or bayonet fastening. Antiseptic is released into the interior (11) of the protective cap by absorption material such as polymer foam or sponge impregnated with the antiseptic.
Patent JP-4066119-B2 (JP)
IPC: A61K6/02
Filed: 1999-11-10
Granted: 2008-03-26
Abstract: Ceramic restauration comprises a glass ceramic containing (in wt.%) 40-95 SiO2, 5-25 Al2O3, 5-25 K2O, 0-25 Na2O, 0-20 CaO, 0-8 B2O3, 0-0.5 P2O5 and 0-3 F. The ceramic additionally contains 20-45 wt.% leucite as single crystal phase. The ceramic restauration has a linear heat expansion coefficient  alpha (20-500oC) of 12.5 - 15.5 x 10<-6> K<-1>. An Independent claim is also included for a process for the production of a ceramic restauration based on leucite-containing glass ceramic comprising: (a) producing a starting glass or glass ceramic containing (in wt.%) 40-95 SiO2, 5-25 Al2O3, 5-25 K2O, 0-25 Na2O, 0-20 CaO, 0-8 B2O3, 0-0.5 P2O5 and 0-3 F in the form of powder or granulate; (b) forming a sintered body in cylinder or pellet form; (c) converting into the viscous state at 850-1200o C and compressing under a pressure of 2-6 bar into a mold corresponding to the dental restauration to form a glass ceramic containing 20-45 wt.% leucite.
Patent JP-H084384-B2 (JP)
IPC: H02M3/315
Filed: 1987-12-28
Abstract: In a resonant regulator power supply, a resonant circuit (10) is coupled to a source (S1,S2) of alternating input voltage that is controllable in operating frequency. A power transformer primary winding (W1) is coupled across the capacitive element (CO) of the resonant circuit (10) for generating an output voltage across a secondary winding (W3). A control circuit (50) varies the operating frequency in a negative feedback loop to regulate the output voltage on the positive slope of the frequency characteristic curve. A frequency limiting circuit (60) prevents the operating frequency from passing through the resonance frequency of the resonant circuit. <IMAGE>
Patent JP-3160105-B2 (JP)
IPC: C07H7/027
Filed: 1992-12-11
Granted: 2001-04-23
Abstract: D-psicofuranose and D-psicopyranose derivatives represented by general formulae (I) and (II), useful as the key intermediates in a novel process for producing hydantocidin; wherein R<1> through R<8> may be the same or different from one another and each represents hydrogen or a hydroxyl-protecting group; and X represents optionally protected hydroxymethyl, carboxyl, carbamoyl or allophanoyl. <CHEM>
Patent JP-4201058-B2 (JP)
IPC: G01N15/00
Filed: 1998-06-10
Granted: 2008-12-24
Abstract: A method for characterizing samples which contain units, comprising the steps of:   a) monitoring intensity fluctuations of radiation emitted, scattered and/or reflected by the units in at least one measurement volume with at least one detection means which is capable to detect radiation emitted, scattered and/or reflected by said units, b) determining at least two-dimensional intermediate statistical data from the detected intensity fluctuations, c) determining the concentration of the units as a function of at least two specific physical properties out of said intermediate statistical data.   <IMAGE>
Patent JP-2971135-B2 (JP)
IPC: C07D417/04
Filed: 1992-07-13
Granted: 1999-11-02
Abstract: PCT No. PCT/EP92/01578 Sec. 371 Date Jan. 14, 1994 Sec. 102(e) Date Jan. 14, 1994 PCT Filed Jul. 13, 1992 PCT Pub. No. WO93/02058 PCT Pub. Date Feb. 4, 1993This invention is directed to anthelmintic benzimidazole compounds of the formula (I),    <IMAGE>  (I)  wherein R1 is C1-C6 alkylthio; R2 is C1-C4 alkyl; and R3 is C1-C4 alkyl.
Patent JP-3996640-B2 (JP)
IPC: C12N15/54
Filed: 1996-06-06
Granted: 2007-10-24
Abstract: A process for increasing the amount of clavam produced by an organism having both a clavam pathway or a portion thereof and a cephalosporin pathway or a portion thereof by interfering with the conversion of L-lysine to L-alpha-aminoadipic acid in the cephalosporin pathway. Plasmids containing a defective LAT (lysine amino transferase) gene and organisms containing such plasmids are also provided.
Patent JP-H0693993-B2 (JP)
IPC: A23L29/00
Filed: 1986-05-29
Abstract: A polyglycerol partial fatty acid ester emulsufier comprising polyglycerol which is predominantly mono- and/or diesterified with saturated fatty acid moieties and optionally monomeric glycerol which is predominantly mono- and/or diesterified with saturated fatty acid moieties, in which the fatty acid moieties are selected so that the average number of carbon atoms in the acid moieties is in the range between 13.0 and 16.5, is prepared by reacting a polyglycerol. optionally containing monomeric glycerol, with a fatty acid or a mixture of fatty acids or with a fatty acid glyceride or a mixture of fatty acid glycerides, the number of carbon atoms of the fatty acid or of the fatty acid moiety of the glyceride or the average number of carbon atoms of the fatty acids or the fatty acid moieties of the glycerides being in the range between 13.0 and 16.5.
Patent JP-3340741-B2 (JP)
IPC: B05B15/04
Filed: 1993-03-16
Granted: 2002-11-05
Abstract: Spray treatment device, particularly for spray-painting of objects, comprising a transport means and collection means for collecting the excess spray medium passing by the objects and the transport means. According to the invention, the collection means comprises an endless rotation belt independent of said transport means. A removal device removes the spray medium from said belt.
Patent JP-2919971-B2 (JP)
IPC: A61J3/06
Filed: 1992-02-21
Granted: 1999-07-19
Abstract: A method of coating substrates of medicinal products with a dry powder includes the following steps: feeding the medicinal substrates onto a conveying belt (1); supplying the dry powder to a region (5) through which the substrates are to be conveyed; conveying the medicinal substrates on the conveying belt (1) through the region (5) with the conveying belt and/or the substrates maintained at a different electric potential from the dry powder, whereby the dry powder is attracted to the exposed surfaces of the substrates but is unable to reach the coated surfaces of the substrates in contact with the conveying belt, and treating the dry powder coatings to convert the powder into a fused film secured to the substrates.
Patent JP-2535504-B2 (JP)
IPC: A61K31/70
Filed: 1985-10-29
Granted: 1996-09-18
Abstract: Adenosine is administered to humans by continuous intravenous infusion at levels at which the heart blocking action of adenosine is not detected, to modify the hemodynamic properties of the patient. Specific indications of use are effecting preferential coronary vasodilation, increasing blood flow in a coronary artery graft and increasing cardiac output.
Patent JP-4197741-B2 (JP)
IPC: C12P17/04
Filed: 1997-07-14
Granted: 2008-12-17
Abstract: PCT No. PCT/EP97/03752 Sec. 371 Date Jan. 22, 1999 Sec. 102(e) Date Jan. 22, 1999 PCT Filed Jul. 14, 1997 PCT Pub. No. WO98/04523 PCT Pub. Date Feb. 5, 19983-Pyrroline-2-carboxylic acid derivatives of the formula I are prepared by eliminating the sulfonic acid residue, with the aid of a base, from a compound of the formula II
Patent JP-2928636-B2 (JP)
IPC: A61N5/06
Filed: 1990-06-15
Granted: 1999-08-03
Abstract: A method for modifying the human endogenous circadian pacemaker is disclosed. The method comprises the steps of determining the characteristics of a desired endogenous circadian cycle for a subject; selecting an appropriate time with respect to the presumed phase of physiological markers of the present endogenous circadian cycle for the subject during which to apply a light stimulus to effect a desired modification of the present endogenous circadian cycle of the subject; and applying said light stimulus at said selected appropriate time to achieve the desired endogenous circadian cycle for the subject. The method finds special utility in treating "jet lag" sufferers, shift workers, advanced circadian phase experienced by many elderly subjects, and those afflicted with delayed sleep phase insomnia.
Patent JP-3568951-B2 (JP)
IPC: C01G27/02
Filed: 1993-10-21
Granted: 2004-09-22
Abstract: A process is disclosed for producing a stabilised hafnium oxide powder or a hafnium oxide-containing powder suitable for compacting molded bodies, then for sintering them into high-density ceramic materials. For that purpose an aqueous solution of hafnium salt containing an additive is transformed into droplets. The thus obtained droplets are consolidated under the action of ammonia into gel particles which are then washed, dewatered, dried and calcined.
Patent JP-2685353-B2 (JP)
IPC: A61K6/00
Filed: 1990-06-20
Granted: 1997-12-03
Abstract: Methods are described for assisting the restoration of periodontal tissue in a periodontal pocket and for retarding migration of epithelial cells along the root surface of a tooth. The methods involve placement of an in-situ forming biodegradable barrier adjacent the surface of a tooth. The barrier is microporous and includes pores of defined size. The barrier can include a biologically active agent.
Patent JP-2509775-B2 (JP)
IPC: C07K14/52
Filed: 1991-06-13
Granted: 1996-06-26
Abstract: A process for crystallizing recombinant human interleukin-4 (rhu IL-4) from a solution containing a sulfate or citrate salt is described. The crystalline form is suitable for x-ray diffraction and has wide applications in several pharmaceutical processes including purification, formulation and manufacturing.
Patent JP-3907700-B2 (JP)
IPC: A61P3/04
Filed: 1995-10-13
Granted: 2007-04-18
Abstract: A pharmaceutical formulation in solid dosage form for oral administration which comprises a compound of general formula (I) or a physiologically salt thereof together with one or more pharmaceutically acceptable carriers wherein the formulation is encased in an enteric coating or capsule.
Patent JP-3159450-B2 (JP)
IPC: F16H21/02
Filed: 1992-12-28
Granted: 2001-04-23
Abstract: A lever device having a point-of-support regulator (12) movably connected to a first motor (14) and a point-of-force regulator (13) movably connected to a second motor (15), wherein the motor (15) is driven in a state in which the motor (14) is stopped, and wherein mold clamping by means of injection molds (20A, 20B) is effected when the motor (15) is driven after the injection mold (20A) has been caused to approach the other mold (20B) that confronts the former. <IMAGE>
Patent JP-4340741-B2 (JP)
IPC: A61P35/00
Filed: 1997-10-17
Granted: 2009-10-07
Abstract: Anthranilic acids of formula (I):wherein each of R to R9 is an organic substituent, n is 0 or 1, m is 0 or an integer of 1 to 6, q is 0 or 1, X is a direct bond, O, S, -S-(CH2)p or -O-(CHO2)p- wherein p is from 1 to 6 and Ar is an unsaturated carbocyclic or heterocyclic group, and the pharmaceutically acceptable salts thereof, have activity as inhibitors of P-glycoprotein and may thus be used, inter alia, as modulators of multidrug resistance in the treatment of multidrug resistant cancers, for example to potentiate the cytotoxicity of a cancer drug.
Patent JP-3742426-B2 (JP)
IPC: C12N5/06
Filed: 1994-03-11
Granted: 2006-02-01
Abstract: Isolated nucleic acids encoding allergens of the species Dermatophagoides pteronyssinus and Dermatophagoides farinae, Der p VII and Der f VII, respectively, are disclosed. A cDNA encoding a peptide having a Der p VII activity and a predicted molecular weight of about 22, 177 daltons is described. A cDNA encoding a peptide having Der f VII activity is also described. The nucleic acids of the invention can be used as probes to detect the presence of Der p VII or Der f VII nucleic acid in a sample or for the recombinant production of peptides having a Der p VII or Der f VII activity. Peptides having a Der p VII or Der f VII activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to house dust mite allergens. <IMAGE>   <IMAGE>
Patent JP-4063869-B2 (JP)
IPC: A61K9/00
Filed: 1996-03-14
Granted: 2008-03-19
Abstract: PCT No. PCT/GB96/00597 Sec. 371 Date Nov. 17, 1997 Sec. 102(e) Date Nov. 17, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/29556 PCT Pub. Date Sep. 26, 1996A process and apparatus for freeze drying of liquid material in a vessel in which the vessels are moved automatically through various stages including loading vessels onto racks, washing vessels in an inverted position, sterilizing vessels and racks, filling vessels with a liquid material, rotating the vessels and the liquid material contained within each vessel at a speed that allows the liquid to form a shell against the inner surface of the vessel, subjecting the vessels and the liquid material contained therein to freezing conditions sufficient to freeze the material into the form of a shell and then moving the rack and the vessels containing the frozen material through a vacuum drying chamber in which the frozen liquid material is dried.
Patent JP-4208261-B2 (JP)
IPC: B67B7/40
Filed: 1998-02-04
Granted: 2009-01-14
Abstract: A closure for a transportable container used in the transfer of materials to or from an enclosed process area is described. The container docks with a port in a wall of the process area forming a sealed connecting chamber which is sterilized by irradiation. Communication between the interiors of the container and the process area is then established. The closure has a collar and a lid, which portions are formed so that all the surfaces which form part of the connecting chamber in use are in the direct line of the sterilizing radiation, which is normally ultra-violet or pulsed white light radiation. No relevant surface is shadowed from the radiation. The lid may be formed integrally with the collar with a thin web separating the two to define a fracture line. The lid is provided with a grip which can be grasped from within the process area. Application of a pulling force to the grip causes the lid to be pealed away from the collar without the generation of particulates.
Patent JP-4080546-B2 (JP)
IPC: C08G59/68
Filed: 1998-01-20
Granted: 2008-04-23
Abstract: The invention relates to epoxy resin compositions. More specifically, the invention is a composition suitable to cure an epoxy resin, preferably in a solvent, incorporating a cross-linking compound of a polycarboxylic acid anhydride or a copolymer of styrene and hydroxystyrene. Also, the invention relates to an epoxy resin composition comprising an inhibitor effective to extend the gel time of the composition at curing temperatures from 150  DEG C to 170  DEG C, and a cross-linking compound as described.
Patent PL-123130-B2 (PL)
Title: Fungicide and method of manufacture of anilides of isoxazolylcarboxylic acid
IPC: A01N43/80
Filed: 1980-10-02
Abstract: New isoxazolylcarboxanilides of the formula    <IMAGE>  I  where R1 is methyl, ethyl or chlorine, R2 is hydrogen, methyl, ethyl, fluorine, chlorine or bromine, R3 is methyl or ethyl, and R4 is hydrogen, methyl or ethyl. These compounds have a fungicidal action and are suitable for combating fungi.
Patent ES-2289875-B2 (ES)
Inventor: SERI MORENO LUIS MIGUEL
IPC: B64F1/36
Filed: 2005-06-24
Granted: 2009-09-11
Abstract: The object of the present invention is to provide a device for extending and retracting an air conditioning hose for aircraft capable of being mounted to the access bridge of the aircraft for its subsequent connection to the air conditioning intake of that aircraft by way of a motor actuating a cable inside the air conditioning hose and circular elastic elements attached to the cable, which, when butting against disks of smaller diameter fastened to the hose, enable the correct extension or retraction of that hose, preventing it from bending or tangling, as well as including rigid elements providing a passage means for the cable guiding it through a telescopic tube provided on the device so as to mount the device to the access bridge of the aircraft.
Patent ES-2371898-B2 (ES)
Title: Nanogeles de ciclodextrina.
Inventor: ALVAREZ LORENZO CARMEN
IPC: A61K47/40
Filed: 2011-09-29
Granted: 2012-06-13
Abstract: Nanogeles de ciclodextrinas y procedimiento de obtención de nanogeles por reticulación/emulsificación/evaporación de la fase orgánica de ciclodextrinas o sus derivados, o ciclodextrinas o sus derivados y polímeros hidrosolubles o sus derivados; utilizando como agente reticulante moléculas que contienen dos o más grupos glicidiléter en su estructura; las composiciones obtenidas capaces de incorporar fármacos y sustancias activas, que forman complejos de inclusión con ciclodextrinas; su uso como componentes de dispositivos de liberación controlada, tales como formas farmacéuticas transdérmicas, formas transmucosales bucales, orales, rectales, oculares, óticas o vaginales, e implantes parenterales, destinadas a administrar fármacos o sustancias activas a humanos, animales o plantas, o como componentes de preparados cosméticos; y el uso de las composiciones como secuestrantes, en la extracción de moléculas tóxicas o biológicas en organismos vivos o de sustancias contaminantes en aguas.
Patent ES-2478691-B2 (ES)
Title: Máquina de compactación de envases
Inventor: VAQUERO SANCHEZ MARCOS
IPC: B65F1/14
Filed: 2013-01-18
Granted: 2015-11-03
Abstract: Máquina de compactación de envases que comprende una estructura soporte (1) a la se fija un motor (2) y una reductora (3), un sistema de compresión mecánica (7) que comprende al menos una placa móvil (9); un cajón (4) deslizable que comprende al menos una placa fija (10) y una placa pivotante (20); y un sistema de calentamiento (8) de los envases; tales que sobre la placa fija (10) del cajón (4) deslizable se deposita el envase a compactar, la placa móvil (9) del sistema de compresión mecánica (7) se desplaza contra la placa fija (10) del cajón (4) deslizable realizando la compactación del envase, y el sistema de calentamiento (8) aporta calor al envase.
Patent ES-2630160-B2 (ES)
Title: Purificador natural de humos
Inventor: GONZALEZ SOBRINO CIPRIANO
IPC: B01D53/78
Filed: 2016-02-17
Granted: 2017-12-22
Abstract: Purificador natural de humos que se instala en grandes hornos, industrias o fábricas con el que se purifica de manera natural y ecológica los humos producidos en la combustión de dichas instalaciones, que está definido por un equipamiento que se ensambla en la zona de salida de humos del horno quemador hacia la chimenea sin cegar la entrada a la chimenea y que dispone de una caldera que genera vapor, y en el que además se coloca una tapa en el conducto de la chimenea por lo que los humos y vapores generados quedan taponados en ese punto, y estos humos se desvían y reconducen por una tubería hacia un purificador o depósito de agua en el cual el humo se limpia de impurezas y finalmente sale a la atmósfera un humo purificado y limpio.
Patent ES-2646727-B2 (ES)
Title: Planta termosolar con calor concentrado indirecto y procedimiento de operación de dicha planta termosolar
Inventor: FERREIRO GARCIA RAMÓN
IPC: F03G6/06
Filed: 2016-06-14
Granted: 2018-07-11
Abstract: La planta termosolar con calor concentrado indirecto y procedimiento de operación de dicha planta termosolar, consiste en una planta térmica que realiza la conversión eficiente de la energía térmica solar concentrada mediante captadores cilindro-parabólicos, disco-parabólicas o campos de heliostatos a energía mecánica y/o eléctrica mediante uno o más cilindros termo-actuadores de doble efecto que operan bajo un ciclo térmico no convencional de alta eficiencia térmica, donde cada cilindro termo-actuador de doble efecto está alimentado por calor indirecto procedente de un intercambiador de calor que a su vez torna el calor de un captador de energía solar concentrada, el cual puede ser aplicado para generar energía eléctrica tanto en la industria terrestre como en la extra-terrestre o aeroespacial.
Patent AU-2001234911-B2 (AU)
Title: Reducing radio link supervision time in a high data rate system
Inventor: HOAGLAND GREG M
IPC: H04B7/00
Filed: 2001-02-07
Granted: 2005-06-09
Abstract: A method of supervising on the forward link in a high data rate system is disclosed, wherein a base station transmits to an access terminal on a forward traffic channel only when the base station has data to send to the access terminal. The base station minimizes the worst-case period necessary to reclaim traffic channel resources following a release by periodically transmitting a configuration packet to its access terminals. The configuration packet indicates the allocation status of the traffic channels belonging to the base station. If an access terminal receives a configuration packet indicating the deallocation of one or all of its traffic channels, the access terminal immediately ceases its use of those traffic channels. If an access terminal fails to successfully decode a configuration packet for a predetermined supervision time, the access terminal releases its connection with all base stations and associated traffic channels.